Published in Vaccine Weekly, January 24th, 2007
The trial is estimated to begin during the first quarter of 2007. The collaboration was initiated in November 2004. This milestone triggers a payment of EUR 2.5 million (US$3.25 million) to Medivir.
"It is extremely pleasing that this project with joint resources and efforts now stands at the threshold of clinical trials. We look forward to 2007 and our continued...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.